Regeneron Pharmaceuticals, Inc.
Glucuronylation as a new acidic post-translational modification on therapeutic monoclonal antibodies
Last updated:
Abstract:
Compositions and methods for identifying glucuronylated protein drug products are provided.
Status:
Grant
Type:
Utility
Filling date:
29 Jan 2019
Issue date:
21 Jun 2022